학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 485건 | 목록 1~20
Academic Journal
Al-Sawaf O; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany.; Stumpf J; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany.; Zhang C; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany.; Simon F; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany.; Bosch F; Department of Hematology, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Barcelona.; Feyzi E; St. Olavs University Hospital, Department of Hematology, Trondheim, Norway.; Ghia P; School of Medicine, Università Vita Salute San Raffaele, Milan.; Comprehensive Cancer Center, IRCCS Ospedale San Raffaele, Milan.; Gregor M; Cantonal Hospital of Lucerne, Lucerne, Switzerland.; Kater AP; Department of Hematology, Cancer Center Amsterdam, Hemato-Oncology Foundation for Adults Netherlands (HOVON), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam.; Lindström V; Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki.; Mattsson M; Uppsala University Hospital, Uppsala, Sweden.; Niemann CU; Rigshospitalet, Copenhagen University Hospital, Copenhagen.; Danish Cancer Institute, Copenhagen.; Staber PB; Medical University Vienna, Vienna, Austria.; Saarland University Medical School, Saarland, Germany.; Tadmor T; Bnai Zion Medical Center, Technion, Haifa, Israel.; Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.; Thornton P; Cancer Clinical Trials and Research Unit, Cancer Trials Ireland, Beaumont Hospital, Dublin.; Wendtner CM; Ludwig-Maximilians University (LMU), Medical Clinic III, Munich, Germany.; Janssens A; Universitaire Ziekenhuizen Leuven, Leuven, Belgium.; Noesslinger T; Hanusch Krankenhaus, Vienna.; Bohn JP; Medical University of Innsbruck, Department of Hematology and Oncology, Innsbruck, Austria.; da Cunha-Bang C; Rigshospitalet, Copenhagen University Hospital, Copenhagen.; Poulsen CB; Zealand University Hospital, Roskilde, Denmark.; Ranti J; Turku University Hospital, Turku, Finland.; Illmer T; Berufsausüebungsgemeinschaft, Gokos, Dresden, Germany.; Schoettker B; Hämatologisch-Onkologische Schwerpunktpraxis, Wuerzburg, Germany.; Böttcher S; Clinic III (Hematology, Oncology, and Palliative Medicine), Rostock University Medical Center, Rostock, Germany.; Gaska T; Bruederkrankenhaus Paderborn, Paderborn, Germany.; Vandenberghe E; Trinity St. James Cancer Institute, Dublin.; Clifford R; University Hospital Limerick, Limerick, Ireland.; Benjamini O; Chaim Sheba Medical Center, Ramat Gan, Israel.; Frustaci AM; ASST Grande Ospedale Metropolitano Niguarda, Milan.; Scarfò L; School of Medicine, Università Vita Salute San Raffaele, Milan.; Comprehensive Cancer Center, IRCCS Ospedale San Raffaele, Milan.; Sportoletti P; Department of Medicine and Surgery, Institute of Hematology and Center for Hemato-Oncology Research (CREO), University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy.; Schreurs J; Martini Ziekenhuis, Groningen, the Netherlands.; Levin MD; Albert Schweitzer Ziekenhuis, Dordrecht, the Netherlands.; van der Straaten H; Ziekenhuis St Jansdal, Harderwijk, the Netherlands.; van der Klift M; Amphia Ziekenhuis, Breda, the Netherlands.; Tran H; Akershus University Hospital, Oslo.; de la Serna J; Hospital Universitario 12 de Octubre, Madrid.; Loscertales J; Hospital Universitario La Princesa, Madrid.; Lindblad O; Skane University Hospital, Lund, Sweden.; Bergendahl Sandstedt A; University Hospital Linköping, Linköping, Sweden.; Goede J; KS Winterthur, Winterthur, Switzerland.; Baumann M; HOCH Health Ostschweiz, Kantonsspital St. Gallen, St. Gallen, Switzerland.; Fink AM; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany.; Fischer K; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany.; Ritgen M; Universitaetsklinikum Schleswig-Holstein, Medizinische Klinik II, Kiel, Germany.; Kreuzer KA; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany.; Schneider C; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany.; Tausch E; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany.; Stilgenbauer S; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany.; Robrecht S; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany.; Eichhorst B; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany.; Hallek M; Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany.
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Academic Journal
Beckers, M. M. J.Bekker, A.Bellido, M.de Boer, F.Broers, R.Chamuleau, M.Croockewit, A. J.Dompeling, E. C.Eefting, M.van Gelder, M.Hoogendoorn, M.Houtenbos, I.Doorduijn, J. K.Droogendijk, J.van der Griend, R.de Heer, K.Henkens, C. M. A.Idink, C. A. M.Issa, D. E.van Kampen, R.Kater, A. P.Kersting, S.van der Klift, M.Laterveer, L.Levenga, H.Levin, M-D.Mous, R.Nijland, M.Nijziel, M.van Norden, Y.Posthuma, E. F. M.te Raa, G. D.Raymakers, R. A. P.Regelink, J. C.Sandberg, Y.Schaafsma, M. R.Silbermann, M. H.van der Spek, A. C.van der Straaten, H. M.Tanis, B.Terpstra, W. E.Tick, L. W.Tonino, S. H.Veelken, J. H.Velders, G. A.Vlasveld, L.Visser, H. P. J.Vos, J. M. I.Wittebol, S.van Zaanen, H. C. T.van der Straten, LinaStege, Claudia A. M.Kersting, SabinaNasserinejad, KazemDubois, JulieDobber, Johan A.Mellink, Clemens H. M.van der Kevie-Kersemaekers, Anne-Marie F.Evers, Ludo M.de Boer, FransienKoene, Harry R.Schreurs, Johnvan der Klift, MarjoleinVelders, Gerjo A.van der Spek, Ellenvan der Straaten, Hanneke M.Hoogendoorn, Melsvan Gelder, MichelPosthuma, Eduardus F. M.Visser, Hein P. J.Houtenbos, IlseIdink, Cecile A. M.Issa, Djamila E.Dompeling, Ellen C.van Zaanen, Henk C. T.Veelken, J. HendrikLevenga, HenrietteTick, Lidwine W.Terpstra, Wim E.Tonino, Sanne H.Westerweel, Peter E.Langerak, Anton W.Kater, Arnon P.Levin, Mark-David
In Blood 28 September 2023 142(13):1131-1142
Academic Journal
Korst CLBM; Department of Hematology and Cancer Center Amsterdam, Amsterdam University Medical Centre (UMC), Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Plattel W; Department of Hematology, UMC Groningen, University Groningen, Groningen, Netherlands.; de Kort EA; Department of Hematology, Radboud UMC, Radboud University, Nijmegen, Netherlands.; Smits F; Department of Hematology and Cancer Center Amsterdam, Amsterdam University Medical Centre (UMC), Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Department of Hematology, Haga Hospital, The Hague, Netherlands.; Croockewit AJ; Department of Hematology, Radboud UMC, Radboud University, Nijmegen, Netherlands.; Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands.; Westerman M; Department of Internal Medicine, Northwest Clinics, Alkmaar, Netherlands.; de Weerdt O; Department of Hematology, St Antonius Hospital, Nieuwegein, Netherlands.; Nijhof IS; Department of Hematology, St Antonius Hospital, Nieuwegein, Netherlands.; Wegman J; Department of Hematology and Cancer Center Amsterdam, Amsterdam University Medical Centre (UMC), Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Smit N; Department of Hematology and Cancer Center Amsterdam, Amsterdam University Medical Centre (UMC), Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Verkleij CPM; Department of Hematology and Cancer Center Amsterdam, Amsterdam University Medical Centre (UMC), Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Mutis T; Department of Hematology and Cancer Center Amsterdam, Amsterdam University Medical Centre (UMC), Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Nasserinejad K; Department of Hematology, Erasmus Medical Centre Cancer Institute, Rotterdam, Netherlands.; Kerstiens R; Department of Clinical Genetics, Amsterdam UMC, Amsterdam, Netherlands.; van der Klift M; Department of Internal Medicine, Amphia Hospital, Breda, Netherlands.; Franssen LE; Department of Internal Medicine, Jeroen Bosch Hospital's-Hertogenbosch, Netherlands.; de Ruijter MEM; Department of Hematology and Cancer Center Amsterdam, Amsterdam University Medical Centre (UMC), Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Groen K; Department of Hematology and Cancer Center Amsterdam, Amsterdam University Medical Centre (UMC), Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; van der Spek E; Department of Internal Medicine, Rijnstate Hospital, Arnhem, Netherlands.; Roeloffzen WWH; Department of Hematology, UMC Groningen, University Groningen, Groningen, Netherlands.; Zweegman S; Department of Hematology and Cancer Center Amsterdam, Amsterdam University Medical Centre (UMC), Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; van de Donk NWCJ; Department of Hematology and Cancer Center Amsterdam, Amsterdam University Medical Centre (UMC), Vrije Universiteit Amsterdam, Amsterdam, Netherlands. Electronic address: n.vandedonk@amsterdamumc.nl.
Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE
Academic Journal
Ehlers LH; Nordic Institute of Health Economics, Aarhus, Denmark.; Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.; van der Klift M; Department of Haematology, Amphia Hospital, Breda, the Netherlands.; Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.; Jensen MB; Nordic Institute of Health Economics, Aarhus, Denmark.; Department of Economics, Aarhus University, Aarhus, Denmark.; Tran HTT; Department of Haematology, Akershus University Hospital, Oslo, Norway.; Kater A; Department of Haematology, Amsterdam University Medical Centers, Amsterdam, the Netherlands.; Niemann CU; Department of Haematology, Rigshospitalet, Copenhagen, Denmark.
Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE
Academic Journal
Ekels A; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. a.ekels@IKNL.nl.; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands. a.ekels@IKNL.nl.; van de Poll-Franse LV; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical and Clinical Psychology, Center of Research on Psychological and Somatic Disorders (CoRPS), Tilburg University, Tilburg, The Netherlands.; Issa DE; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.; Hoogendoorn M; Department of Hematology, Medical Center Leeuwarden, Leeuwarden, The Netherlands.; Nijziel MR; Department of Hemato-oncology, Catharina Cancer Institute, Catharina Hospital, Eindhoven, The Netherlands.; Koster A; Department of Internal Medicine, VieCuri Medical Centre, Venlo and Venray, The Netherlands.; de Jong CN; Department of Internal Medicine, Gelderse Vallei Hospital, Ede, The Netherlands.; Achouiti A; Department of Internal Medicine, St. Jansdal Hospital, Harderwijk, The Netherlands.; Thielen N; Department of Internal Medicine, Diakonessenhuis, Utrecht, The Netherlands.; Tick LW; Department of Internal Medicine, Máxima Medical Centre, Eindhoven, The Netherlands.; Te Boome LCJ; Department of Internal Medicine, Haaglanden Medical Center, The Hague, The Netherlands.; Bohmer LH; Department of Hematology, Haga Teaching Hospital, The Hague, The Netherlands.; Tiren-Verbeet NL; Department of Internal Medicine, Groene Hart Hospital, Gouda, The Netherlands.; Veldhuis GJ; Department of Internal Medicine, Antonius Hospital, Sneek, The Netherlands.; de Boer F; Department of Internal Medicine, Ikazia Hospital, Rotterdam, The Netherlands.; van der Klift M; Department of Haematology, Amphia, Breda, The Netherlands.; Posthuma EFM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Department of Internal Medicine, Reinier de Graaf Group, Delft, The Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.; Oerlemans S; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. s.oerlemans@IKNL.nl.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Academic Journal
Ossenkoppele, G J, Breems, D A, Stuessi, G, van Norden, Y, Bargetzi, M, Biemond, B J, A von dem Borne, P, Chalandon, Y, Cloos, J, Deeren, D, Fehr, M, Gjertsen, B T, Graux, C, Huls, G, Janssen, J J J W, Jaspers, A, Jongen-Lavrencic, M, de Jongh, E, Klein, S K, Van der Klift, M, Van Marwijk Kooy, M, Maertens, J, Michaux, L, van der Poel, M W M, Van Rhenen, A, Tick, L, Valk, P, Vekemans, M C, van der Velden, W J F M, de Weerdt, O, Pabst, T, Manz, M, Löwenberg, B, Breems, D A, Havelange, Vekemans, M C, Moors, I, van Obberg, F, Maertens, J A, Hodossy, B, Vansteenweghen, S, Lammertijn, L, Deeren, D, Graux, C, Sonet, A, Triffet, A, Gjertsen, B T, Bargetzi, M, Passweg, J, Heim, D, Giovanni, S, Stuessi, G, Pabst, T, Betticher, D, Chalandon, Y, Spertini, O, Gregor, M, Hess, U, Fehr, M, Manz, M G, Klein, S K, Biemond, B J, Ossenkoppele, G J, van de Loosdrecht, A, Janssen, J J W M, van Esser, J W J, Van der Klift, M, Brouwer, R E, Van Lammeren-Venema, D, Levin, M D, Tick, L W, Legdeur, M C J C, Huls, G, Vellenga, E, Hoogendoorn, M, Veelken, J H, von dem Borne, P A, Schouten, H C, de Weerdt, O, van der Velden, W J F M, Cornelissen, J, Jongen-Lavrencic, M, Wouters, B, Raaijmakers, H G M, Löwenberg, B, Kuball, J, Van Rhenen, A, Van Marwijk Kooy, M & for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) 2020, 'Correction : Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS (Leukemia, (2020), 34, 7, (1751-1759), 10.1038/s41375-020-0725-0)', Leukemia, vol. 34, no. 10. https://doi.org/10.1038/s41375-020-0994-7
Academic Journal
Raa DGT; Department of Internal Medicine, Gelderse Vallei, Ede, the Netherlands.; van der Straten L; Department of Internal Medicine, Albert Schweitzer hospital, Dordrecht, the Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, Rotterdam, The Netherlands.; van Gelder M; Department of Hematology, Maastricht UMC, the Netherlands Maastricht.; Kersting S; Department of Internal Medicine, HAGA hospital, Den Haag, the Netherlands.; Levin MD; Department of Internal Medicine, Albert Schweitzer hospital, Dordrecht, the Netherlands.; Mous R; Department of Hematology, UMC Utrecht, the Netherlands Utrecht.; van der Straaten HM; Department of Internal Medicine, St Jansdal hospital, Harderwijk, the Netherlands.; Nijziel MR; Department of Internal Medicine, Catharina hospital, Eindhoven, the Netherlands.; van der Spek E; Department of Internal Medicine, Rijnstate, Arnhem, the Netherlands.; Posthuma EFM; Department of Internal Medicine, Reinier de Graaf hospital, Delft, the Netherlands.; Department of Hematology, Leiden Univerisity Medical Center, Leiden, the Netherlands.; Visser HPJ; Department of Internal Medicine, Noordwest ziekenhuisgroep, Alkmaar, the Netherlands.; van der Klift M; Department of Internal Medicine Amphia hospital, Breda, the Netherlands.; de Heer K; Department of Internal Medicine, Flevo hospital, Almere, the Netherlands.; Bellido M; Department of Hematology, Groningen University Medical Center, University of Groningen, Groningen, the Netherlands.; Doorduijn JK; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Bruns AHW; Department of Hematology, UMC Utrecht, the Netherlands Utrecht.; Raijmakers RAP; Department of Hematology, UMC Utrecht, the Netherlands Utrecht.; Kater AP; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam UMC, Amsterdam, University of Amsterdam, Amsterdam, the Netherlands.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Van der Klift, M.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어